CMS Ends Medicare Part D Premium Program Before 2027
CMS will end the temporary Medicare Part D Premium Stabilization Demonstration before the 2027 plan year, changing how some beneficiaries may experience prescription-drug costs.
CMS will end the temporary Medicare Part D Premium Stabilization Demonstration before the 2027 plan year, changing how some beneficiaries may experience prescription-drug costs.
The Trump administration is ending a temporary Medicare Part D subsidy that offset an average of $16 per person in 2026. Beneficiaries could face higher monthly costs in 2027 as plans finalize offerings.
CMS will end a temporary Medicare Part D program after 2026. MedPAC estimated it reduced the average standalone drug-plan premium by $16 in 2026, potentially increasing costs for some enrollees in 2027.
A new CMS demonstration began July 1, 2026, offering eligible Medicare Part D beneficiaries certain GLP-1 medications for $50 per monthly supply through the end of 2027.
The Centers for Medicare & Medicaid Services said it would end a prescription-drug subsidy program created in 2024. The effect on beneficiaries will vary.
The Trump administration is ending a temporary Medicare Part D subsidy that reduced average premiums by about $16 in 2026, a change expected to raise costs for many older adults in 2027.
CMS will end a temporary Medicare Part D premium stabilization program after 2026. Some seniors could pay more in 2027, but final plan prices come in September.
CMS will end a temporary premium stabilization program for stand-alone Medicare Part D plans after 2026. Final 2027 plan premiums are expected in September.